For the first time, CM from MSCs preconditioned with a TLR3 ligand or the hypoxia mimetic CoCl2 has been shown to have enhanced neuroprotective properties in an in vitro model of Alzheimer’s disease compared with CM derived from untreated MSCs. The gene discussed is TLR3; the disease is early-onset autosomal dominant Alzheimer disease.